×
S&P 500   3,941.48
DOW   31,928.62
QQQ   287.24
S&P 500   3,941.48
DOW   31,928.62
QQQ   287.24
S&P 500   3,941.48
DOW   31,928.62
QQQ   287.24
S&P 500   3,941.48
DOW   31,928.62
QQQ   287.24

Chardan Capital Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Chardan Capital. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Chardan Capital.

MarketRank evaluates a company based on community opinion, dividend strength, institutional and insider ownership, earnings and valuation, and analysts forecasts.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyDateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActions
RCKT
Rocket Pharmaceuticals
5/19/2022Target Raised byChardan CapitalBuy$60.00 -> $62.00High
TSHA
Taysha Gene Therapies
5/17/2022Target Lowered byChardan Capital$37.00 -> $34.00Medium
FIXX
Homology Medicines
5/17/2022Target Lowered byChardan CapitalAnalyst M. BarcusNA $14.00High
PEAR
Pear Therapeutics
5/17/2022Target Lowered byChardan CapitalAnalyst K. NakaeBuy$16.00 -> $13.00High
BTTX
Better Therapeutics
5/16/2022Target Lowered byChardan CapitalAnalyst K. NakaeNA $15.00Low
MGTX
MeiraGTx
5/13/2022Reiterated byChardan CapitalAnalyst Geulah LivshitsBuy $46.00Medium
RCOR
Renovacor
5/13/2022Reiterated byChardan CapitalAnalyst Geulah LivshitsBuy $20.00High
SABS
SAB Biotherapeutics
5/13/2022Target Lowered byChardan CapitalAnalyst K. Nakae$10.00 -> $7.00High
NBSE
NeuBase Therapeutics
5/13/2022Target Lowered byChardan Capital$18.00 -> $9.00Medium
IMNM
Immunome
5/13/2022Target Lowered byChardan Capital$16.00 -> $9.00High
CRSP
CRISPR Therapeutics
5/10/2022Target Lowered byChardan Capital$171.00 -> $168.00High
OCGN
Ocugen
5/9/2022Target Lowered byChardan CapitalAnalyst D. GataulinNeutral -> Neutral$4.00 -> $3.50High
AXLA
Axcella Health
5/9/2022Target Lowered byChardan CapitalBuy$12.00 -> $7.00High
EBS
Emergent BioSolutions
4/29/2022Target Lowered byChardan Capital$75.00 -> $65.00High
SLDB
Solid Biosciences
4/28/2022Target Lowered byChardan Capital$17.00 -> $7.00High
VBLT
Vascular Biogenics
4/28/2022Initiated byChardan CapitalAnalyst M. BarcusBuy $5.00High
PRQR
ProQR Therapeutics
4/14/2022Target Lowered byChardan CapitalBuy$8.00 -> $2.50High
RGNX
REGENXBIO
4/11/2022Reiterated byChardan CapitalAnalyst D. GataulinBuyMedium
KOD
Kodiak Sciences
4/11/2022Reiterated byChardan CapitalAnalyst D. GataulinBuyHigh
ADVM
Adverum Biotechnologies
4/11/2022Reiterated byChardan CapitalAnalyst D. GataulinNeutralMedium
OCGN
Ocugen
4/11/2022Reiterated byChardan CapitalAnalyst D. GataulinNeutralHigh
AGTC
Applied Genetic Technologies
4/11/2022Reiterated byChardan CapitalAnalyst D. GataulinBuyHigh
SABS
SAB Biotherapeutics
4/1/2022Target Lowered byChardan CapitalAnalyst K. NakaeBuy$17.00 -> $10.00Low
VINC
Vincerx
3/29/2022Reiterated byChardan CapitalAnalyst Y. LivshitsBuyLow
IMVT
Immunovant
3/29/2022Reiterated byChardan CapitalAnalyst Y. LivshitsBuyMedium
FIXX
Homology Medicines
3/29/2022Reiterated byChardan CapitalAnalyst Y. LivshitsBuyHigh
TSHA
Taysha Gene Therapies
3/31/2022Target Lowered byChardan Capital$60.00 -> $37.00High
WBX
Wallbox
3/31/2022Initiated byChardan CapitalBuy $19.00Low
OUST
Ouster
3/31/2022Initiated byChardan CapitalBuy $7.00High
SLN
Silence Therapeutics
3/31/2022Initiated byChardan CapitalAnalyst K. NakaeBuy $33.00Low
PHGE
BiomX
3/31/2022Target Lowered byChardan Capital$13.00 -> $12.00N/A
QURE
uniQure
3/30/2022Target Lowered byChardan CapitalAnalyst M. Barcus$95.00 -> $65.00Low
VINC
Vincerx
3/30/2022Target Lowered byChardan CapitalAnalyst M. Barcus$30.00 -> $14.00Low
IMVT
Immunovant
3/30/2022Target Lowered byChardan CapitalAnalyst M. Barcus$20.00 -> $14.00High
IMNM
Immunome
3/30/2022Target Lowered byChardan Capital$21.00 -> $16.00High
RGNX
REGENXBIO
3/29/2022Target Lowered byChardan Capital$90.00 -> $76.00High
OCGN
Ocugen
3/29/2022Target Lowered byChardan Capital$4.50 -> $4.00High
KOD
Kodiak Sciences
3/29/2022Target Lowered byChardan Capital$82.50 -> $19.00High
VINC
Vincerx
3/22/2022Reiterated byChardan CapitalAnalyst M. BarcusBuyMedium
QURE
uniQure
3/22/2022Reiterated byChardan CapitalAnalyst M. BarcusBuyMedium
IMVT
Immunovant
3/22/2022Reiterated byChardan CapitalAnalyst M. BarcusBuyLow
FIXX
Homology Medicines
3/22/2022Reiterated byChardan CapitalAnalyst M. BarcusBuyLow
FEMY
Femasys
3/25/2022Target Lowered byChardan CapitalBuy$25.00 -> $18.00Medium
BTTX
Better Therapeutics
3/16/2022Target Raised byChardan CapitalAnalyst K. NakaeBuy$17.00 -> $18.00High
PASG
Passage Bio
3/11/2022Target Lowered byChardan Capital$43.00 -> $34.00Low
VYGR
Voyager Therapeutics
3/9/2022Target Raised byChardan Capital$4.00 -> $6.00High
ABUS
Arbutus Biopharma
3/4/2022Target Raised byChardan CapitalBuy$5.50 -> $6.00High
PLBY
PLBY Group
3/2/2022Target Lowered byChardan CapitalBuy$49.00 -> $39.00High
NTLA
Intellia Therapeutics
3/1/2022Target Lowered byChardan CapitalAnalyst Geulah LivshitsBuy$177.00 -> $172.00High
EDIT
Editas Medicine
2/25/2022Target Lowered byChardan CapitalAnalyst Geulah LivshitsBuy$75.00 -> $60.00High
IOVA
Iovance Biotherapeutics
2/25/2022Target Lowered byChardan CapitalBuy$50.00 -> $45.00High
FIXX
Homology Medicines
2/22/2022Target Lowered byChardan CapitalBuy$25.00 -> $15.00High
PRQR
ProQR Therapeutics
2/14/2022Target Lowered byChardan CapitalAnalyst Keay NakaeBuy$18.00 -> $8.00High
ALNY
Alnylam Pharmaceuticals
2/11/2022Reiterated byChardan CapitalAnalyst Keay NakaeBuy $200.00Medium
LOGC
LogicBio Therapeutics
2/2/2022Target Lowered byChardan CapitalHold$16.00 -> $6.00High
TNYA
Tenaya Therapeutics
1/17/2022Reiterated byChardan CapitalAnalyst Y. LivshitsBuyLow
LICY
Li-Cycle
1/13/2022Target Raised byChardan CapitalBuy$17.00 -> $18.00Medium
IMVT
Immunovant
1/5/2022Target Lowered byChardan CapitalAnalyst M. BarcusBuy -> Buy$22.00 -> $20.00High
PEAR
Pear Therapeutics
12/22/2021Reiterated byChardan CapitalAnalyst K. NakaeBuyHigh
LOGC
LogicBio Therapeutics
12/23/2021Target Lowered byChardan CapitalAnalyst M. BarcusBuy$20.00 -> $16.00Medium
NVVE
Nuvve
12/21/2021Initiated byChardan CapitalBuy $24.00High
SONN
Sonnet BioTherapeutics
12/20/2021Target Lowered byChardan CapitalAnalyst K. NakaeBuy$8.00 -> $2.50High
VINC
Vincerx
12/17/2021Reiterated byChardan CapitalAnalyst Geulah LivshitsBuy $30.00Medium
RCKT
Rocket Pharmaceuticals
12/15/2021Target Raised byChardan CapitalAnalyst Geulah LivshitsBuy$56.00 -> $60.00High
XCUR
Exicure
12/13/2021Downgraded byChardan CapitalAnalyst K. NakaeBuy -> NeutralHigh
ABUS
Arbutus Biopharma
12/2/2021Target Raised byChardan CapitalBuy$5.00 -> $5.50High
BTTX
Better Therapeutics
11/24/2021Initiated byChardan CapitalAnalyst K. NakaeBuy $17.00High
XCUR
Exicure
11/23/2021Target Lowered byChardan CapitalBuy$7.00 -> $2.25Low
BMTX
BM Technologies
11/23/2021Initiated byChardan CapitalBuy $21.00High
LTRY
Lottery.com
11/23/2021Initiated byChardan CapitalBuy $14.00Medium
VLN
Valens Semiconductor
11/23/2021Initiated byChardan CapitalBuy $13.00High
LICY
Li-Cycle
11/23/2021Initiated byChardan CapitalBuy $17.00High
PLBY
PLBY Group
11/23/2021Initiated byChardan CapitalBuy $49.00Low
PHGE
BiomX
11/16/2021Target Lowered byChardan CapitalBuy$16.00 -> $13.00N/A
AXLA
Axcella Health
11/16/2021Target Raised byChardan CapitalAnalyst Keay NakaeBuy$10.00 -> $12.00Low
FIXX
Homology Medicines
11/16/2021Target Lowered byChardan CapitalAnalyst M. BarcusBuy$30.00 -> $25.00High
EBS
Emergent BioSolutions
11/10/2021Target Lowered byChardan CapitalBuy$92.00 -> $75.00Low
SABS
SAB Biotherapeutics
11/5/2021Initiated byChardan CapitalAnalyst K. NakaeBuy $17.00Low
ABUS
Arbutus Biopharma
11/4/2021Reiterated byChardan CapitalBuyMedium
RGNX
REGENXBIO
11/3/2021Target Lowered byChardan CapitalAnalyst Geulah LivshitsBuy$100.00 -> $90.00High
VYGR
Voyager Therapeutics
11/2/2021Target Lowered byChardan CapitalAnalyst Y. LivshitsNeutral$5.50 -> $4.00Low
EVLO
Evelo Biosciences
11/1/2021Upgraded byChardan CapitalAnalyst Keay NakaeNeutral -> Buy $12.00Medium
ALNY
Alnylam Pharmaceuticals
10/29/2021Target Raised byChardan CapitalAnalyst Keay NakaeBuy$190.00 -> $200.00High
PHGE
BiomX
10/19/2021Target Lowered byChardan CapitalBuy$28.00 -> $16.00N/A
ABUS
Arbutus Biopharma
10/17/2021Reiterated byChardan CapitalBuyHigh
CRSP
CRISPR Therapeutics
10/13/2021Reiterated byChardan CapitalAnalyst Geulah LivshitsBuy $171.00Low
RCOR
Renovacor
10/1/2021Initiated byChardan CapitalBuy $20.00Low
EDIT
Editas Medicine
9/30/2021Reiterated byChardan CapitalAnalyst Geulah LivshitsBuy $75.00Medium
SLDB
Solid Biosciences
9/24/2021Target Lowered byChardan CapitalAnalyst Y. LivshitsBuy$20.00 -> $17.00High
NTLA
Intellia Therapeutics
9/16/2021Reiterated byChardan CapitalAnalyst Geulah LivshitsBuy $177.00Low
PRQR
ProQR Therapeutics
9/10/2021Reiterated byChardan CapitalAnalyst Keay NakaeBuy $18.00Medium
RCKT
Rocket Pharmaceuticals
9/7/2021Reiterated byChardan CapitalAnalyst Geulah LivshitsBuyMedium
NVAX
Novavax
9/1/2021Reiterated byChardan CapitalAnalyst K. NakaeNeutralN/A
FBRX
Forte Biosciences
9/3/2021Downgraded byChardan CapitalAnalyst Keay NakaeBuy -> SellN/A
MESO
Mesoblast
8/31/2021Target Lowered byChardan CapitalSell$7.50 -> $6.50High
ABUS
Arbutus Biopharma
8/31/2021Reiterated byChardan CapitalBuyLow
TNYA
Tenaya Therapeutics
8/24/2021Initiated byChardan CapitalBuy $37.00Medium
IMNM
Immunome
8/20/2021Target Raised byChardan CapitalAnalyst M. BarcusBuy$18.00 -> $21.00High
TSHA
Taysha Gene Therapies
8/17/2021Target Lowered byChardan CapitalAnalyst Y. LivshitsBuy$67.50 -> $60.00High
VINC
Vincerx
8/13/2021Target Lowered byChardan CapitalBuy$33.00 -> $30.00High
IMVT
Immunovant
8/13/2021Target Lowered byChardan CapitalAnalyst M. BarcusBuy$55.00 -> $22.00High
RCKT
Rocket Pharmaceuticals
8/10/2021Reiterated byChardan CapitalAnalyst Geulah LivshitsBuy $56.00Medium
RGNX
REGENXBIO
8/10/2021Reiterated byChardan CapitalAnalyst Geulah LivshitsBuy $100.00Low
PRQR
ProQR Therapeutics
8/9/2021Target Lowered byChardan CapitalBuy$20.00 -> $18.00Low
NTLA
Intellia Therapeutics
8/6/2021Target Raised byChardan CapitalAnalyst M. BarcusBuy$130.00 -> $177.00Low
ARWR
Arrowhead Pharmaceuticals
8/6/2021Target Lowered byChardan CapitalBuy$97.00 -> $94.00High
ALNY
Alnylam Pharmaceuticals
8/4/2021Reiterated byChardan CapitalAnalyst Keay NakaeBuy $190.00Medium
MCRB
Seres Therapeutics
8/4/2021Reiterated byChardan CapitalAnalyst Keay NakaeBuy $16.00Medium
AXLA
Axcella Health
7/30/2021Reiterated byChardan CapitalAnalyst Keay NakaeBuy $10.00Low
CRSP
CRISPR Therapeutics
7/30/2021Target Lowered byChardan CapitalAnalyst M. BarcusBuy$175.00 -> $171.00High
EVLO
Evelo Biosciences
7/30/2021Target Lowered byChardan CapitalAnalyst Keay NakaeNeutral$15.00 -> $12.00High
QURE
uniQure
7/27/2021Reiterated byChardan CapitalAnalyst Y. LivshitsBuy$100.00 -> $95.00High
ADVM
Adverum Biotechnologies
7/23/2021Target Lowered byChardan CapitalAnalyst Y. LivshitsNeutral$5.00 -> $3.00High
MCRB
Seres Therapeutics
7/23/2021Target Lowered byChardan CapitalAnalyst Keay NakaeBuy$30.00 -> $16.00Medium
FEMY
Femasys
7/13/2021Initiated byChardan CapitalAnalyst K. NakaeBuy $25.00High
FBRX
Forte Biosciences
7/9/2021Initiated byChardan CapitalAnalyst Keay NakaeBuy $105.00High
EVLO
Evelo Biosciences
7/9/2021Initiated byChardan CapitalAnalyst Keay NakaeHold $15.00Low
MCRB
Seres Therapeutics
7/9/2021Initiated byChardan CapitalAnalyst Keay NakaeBuy $30.00Low
SYBX
Synlogic
7/9/2021Initiated byChardan CapitalAnalyst Keay NakaeBuy $10.00Medium
RCKT
Rocket Pharmaceuticals
7/7/2021Reiterated byChardan CapitalAnalyst M. BarcusBuyLow
PDSB
PDS Biotechnology
7/7/2021Reiterated byChardan CapitalAnalyst M. BarcusBuyHigh
NTLA
Intellia Therapeutics
7/7/2021Reiterated byChardan CapitalAnalyst M. BarcusBuyMedium
MRNA
Moderna
7/7/2021Reiterated byChardan CapitalAnalyst M. BarcusBuyHigh
LOGC
LogicBio Therapeutics
7/7/2021Reiterated byChardan CapitalAnalyst M. BarcusBuyLow
IOVA
Iovance Biotherapeutics
7/7/2021Reiterated byChardan CapitalAnalyst M. BarcusBuyHigh
IMVT
Immunovant
7/7/2021Reiterated byChardan CapitalAnalyst M. BarcusBuyLow
IMTX
Immatics
7/7/2021Reiterated byChardan CapitalAnalyst M. BarcusBuyLow
IMNM
Immunome
7/7/2021Reiterated byChardan CapitalAnalyst M. BarcusBuyMedium
FIXX
Homology Medicines
7/7/2021Reiterated byChardan CapitalAnalyst M. BarcusBuyMedium
EDIT
Editas Medicine
7/7/2021Reiterated byChardan CapitalAnalyst M. BarcusBuyMedium
CRSP
CRISPR Therapeutics
7/7/2021Reiterated byChardan CapitalAnalyst M. BarcusBuyMedium
ACHL
Achilles Therapeutics
7/7/2021Reiterated byChardan CapitalAnalyst M. BarcusBuyMedium
SIOX
Sio Gene Therapies
7/7/2021Reiterated byChardan CapitalAnalyst G. AmusaBuyMedium
LBPS
4D pharma
7/7/2021Reiterated byChardan CapitalAnalyst G. AmusaBuy $40.00Medium
CFRX
ContraFect
7/1/2021Reiterated byChardan CapitalAnalyst K. NakaeBuyMedium
VYGR
Voyager Therapeutics
7/1/2021Reiterated byChardan CapitalAnalyst Y. LivshitsNeutralHigh
TSHA
Taysha Gene Therapies
7/1/2021Reiterated byChardan CapitalAnalyst Y. LivshitsBuyHigh
SLDB
Solid Biosciences
7/1/2021Reiterated byChardan CapitalAnalyst Y. LivshitsBuyHigh
RGNX
REGENXBIO
7/1/2021Reiterated byChardan CapitalAnalyst Y. LivshitsBuyLow
QURE
uniQure
7/1/2021Reiterated byChardan CapitalAnalyst Y. LivshitsBuyHigh
PRVB
Provention Bio
7/1/2021Reiterated byChardan CapitalAnalyst Y. LivshitsBuyMedium
PASG
Passage Bio
7/1/2021Reiterated byChardan CapitalAnalyst Y. LivshitsBuyMedium
MGTX
MeiraGTx
7/1/2021Reiterated byChardan CapitalAnalyst Y. LivshitsBuyLow
MCRB
Seres Therapeutics
7/1/2021Reiterated byChardan CapitalAnalyst K. NakaeBuyLow
KRYS
Krystal Biotech
7/1/2021Reiterated byChardan CapitalAnalyst Y. LivshitsBuyMedium
IMVT
Immunovant
7/1/2021Reiterated byChardan CapitalAnalyst Y. LivshitsBuyMedium
FOLD
Amicus Therapeutics
7/1/2021Reiterated byChardan CapitalAnalyst Y. LivshitsNeutralMedium
FBRX
Forte Biosciences
7/1/2021Reiterated byChardan CapitalAnalyst K. NakaeBuyHigh
EVLO
Evelo Biosciences
7/1/2021Reiterated byChardan CapitalAnalyst K. NakaeNeutralLow
CBIO
Catalyst Biosciences
7/1/2021Reiterated byChardan CapitalAnalyst Y. LivshitsBuyHigh
AGTC
Applied Genetic Technologies
7/1/2021Reiterated byChardan CapitalAnalyst Y. LivshitsBuyMedium
ADVM
Adverum Biotechnologies
7/1/2021Reiterated byChardan CapitalAnalyst Y. LivshitsNeutralMedium
SIOX
Sio Gene Therapies
7/1/2021Reiterated byChardan CapitalAnalyst G. AmusaBuyN/A
IOVA
Iovance Biotherapeutics
6/29/2021Reiterated byChardan CapitalAnalyst Geulah LivshitsBuy $51.00High
NTLA
Intellia Therapeutics
6/26/2021Target Raised byChardan CapitalAnalyst Geulah LivshitsBuy$85.00 -> $130.00High
OCGN
Ocugen
6/10/2021Target Lowered byChardan CapitalAnalyst K. NakaeNeutral$8.00 -> $4.50N/A
VBLT
Vascular Biogenics
6/3/2021Reiterated byChardan CapitalAnalyst Geulah LivshitsBuy $5.00High
AXLA
Axcella Health
6/3/2021Target Lowered byChardan CapitalAnalyst K. NakaeBuy$16.00 -> $10.00Low
LOGC
LogicBio Therapeutics
6/2/2021Reiterated byChardan CapitalAnalyst Geulah LivshitsBuy $20.00High
PRVB
Provention Bio
5/28/2021Target Lowered byChardan CapitalBuy$35.00 -> $22.50High
PHGE
BiomX
5/25/2021Reiterated byChardan CapitalBuy $28.00N/A
PDSB
PDS Biotechnology
5/20/2021Target Raised byChardan CapitalAnalyst Geulah LivshitsBuy$10.00 -> $11.00High
IOVA
Iovance Biotherapeutics
5/19/2021Target Lowered byChardan CapitalAnalyst Y. LivshitsBuy$54.00 -> $51.00High
OCGN
Ocugen
5/10/2021Target Lowered byChardan CapitalAnalyst K. NakaeNeutral$13.00 -> $8.00High
MRNA
Moderna
5/7/2021Target Raised byChardan CapitalBuy$182.00 -> $188.00Low
ADVM
Adverum Biotechnologies
5/5/2021Reiterated byChardan CapitalAnalyst G. AmusaBuy -> Neutral$20.00 -> $5.00Low
EBS
Emergent BioSolutions
4/30/2021Target Lowered byChardan CapitalAnalyst K. NakaeBuy$112.00 -> $92.00Medium
ADVM
Adverum Biotechnologies
4/29/2021Downgraded byChardan CapitalAnalyst G. AmusaBuy -> Neutral$20.00 -> $5.00N/A
TSHA
Taysha Gene Therapies
4/26/2021Reiterated byChardan CapitalAnalyst G. AmusaBuyMedium
ACHL
Achilles Therapeutics
4/26/2021Initiated byChardan CapitalAnalyst Y. LivshitsBuy $27.00Medium
TSHA
Taysha Gene Therapies
4/12/2021Target Raised byChardan CapitalAnalyst G. AmusaBuy$60.00 -> $67.50High
PRVB
Provention Bio
4/12/2021Target Lowered byChardan CapitalBuy$35.00 -> $22.50Low
PDSB
PDS Biotechnology
4/10/2021Reiterated byChardan CapitalAnalyst Geulah LivshitsBuy $10.00High
LBPS
4D pharma
4/7/2021Reiterated byChardan CapitalAnalyst G. AmusaBuyMedium
LCTX
Lineage Cell Therapeutics
4/7/2021Reiterated byChardan CapitalBuy $4.00N/A
IMTX
Immatics
4/4/2021Reiterated byChardan CapitalBuyMedium
CWBR
CohBar
3/31/2021Target Raised byChardan CapitalAnalyst M. MorabitoBuy$3.00 -> $3.50High
ETNB
89bio
3/25/2021Target Raised byChardan CapitalBuy$92.00 -> $95.00High
FBRX
Forte Biosciences
3/17/2021Target Lowered byChardan CapitalBuy$115.00 -> $105.00High
AKRO
Akero Therapeutics
3/17/2021Target Raised byChardan CapitalPositive -> Buy$79.00 -> $81.00High
SLDB
Solid Biosciences
3/16/2021Target Raised byChardan CapitalAnalyst Gbola AmusaBuy$12.50 -> $20.00High
CFRX
ContraFect
3/16/2021Target Raised byChardan CapitalBuy$15.00 -> $17.50Low
EVLO
Evelo Biosciences
3/12/2021Target Raised byChardan CapitalNeutral$10.00 -> $15.00Low
LJPC
La Jolla Pharmaceutical
3/10/2021Reiterated byChardan CapitalBuy $15.00High
PASG
Passage Bio
3/8/2021Target Raised byChardan CapitalAnalyst Gbola AmusaBuy$35.50 -> $45.00High
MCRB
Seres Therapeutics
3/5/2021Upgraded byChardan CapitalAnalyst G. AmusaNeutral -> Buy$27.50 -> $30.00High
NGM
NGM Biopharmaceuticals
3/5/2021Target Raised byChardan CapitalBuy$39.00 -> $44.00High
TSHA
Taysha Gene Therapies
3/4/2021Target Raised byChardan CapitalAnalyst G. AmusaBuy$45.00 -> $60.00Low
MDGL
Madrigal Pharmaceuticals
3/4/2021Target Raised byChardan CapitalBuy$202.00 -> $203.00High
IOVA
Iovance Biotherapeutics
3/1/2021Reiterated byChardan CapitalAnalyst Y. LivshitsBuyHigh
QURE
uniQure
3/2/2021Target Raised byChardan CapitalBuy$85.00 -> $100.00High
ICPT
Intercept Pharmaceuticals
3/1/2021Target Lowered byChardan CapitalBuy$58.00 -> $45.00Low
MRNA
Moderna
3/1/2021Target Raised byChardan CapitalAnalyst Geulah LivshitsPositive -> Buy$107.00 -> $182.00Low
MDGL
Madrigal Pharmaceuticals
2/26/2021Target Raised byChardan CapitalBuy$202.00 -> $203.00Medium
PRVB
Provention Bio
2/25/2021Target Lowered byChardan CapitalBuy$40.00 -> $35.00High
EBS
Emergent BioSolutions
2/24/2021Upgraded byChardan CapitalAnalyst K. NakaeNeutral -> Buy $112.00Low
IMUX
Immunic
2/18/2021Reiterated byChardan CapitalAnalyst K. NakaeBuyMedium
EBS
Emergent BioSolutions
2/19/2021Downgraded byChardan CapitalAnalyst K. NakaeBuy -> Neutral $112.00High
CRSP
CRISPR Therapeutics
2/17/2021Target Raised byChardan CapitalBuy$166.00 -> $175.00Low
NTLA
Intellia Therapeutics
2/10/2021Target Raised byChardan CapitalBuy$57.50 -> $85.00Low
EDIT
Editas Medicine
2/10/2021Target Raised byChardan CapitalBuy$55.00 -> $77.00Low
OCGN
Ocugen
2/9/2021Downgraded byChardan CapitalAnalyst Keay NakaeBuy -> NeutralLow
ARWR
Arrowhead Pharmaceuticals
2/5/2021Target Raised byChardan CapitalBuy$81.00 -> $97.00High
DRRX
DURECT
2/3/2021Target Raised byChardan CapitalAnalyst M. MorabitoBuy$7.00 -> $8.00High
VYGR
Voyager Therapeutics
2/3/2021Target Lowered byChardan CapitalAnalyst Gbola AmusaNeutral$15.00 -> $6.50High
SYBX
Synlogic
1/13/2021Target Raised byChardan CapitalBuy$5.00 -> $10.00High
SLDB
Solid Biosciences
1/8/2021Reiterated byChardan CapitalAnalyst Gbola AmusaBuy $12.50High
CABA
Cabaletta Bio
1/8/2021Reiterated byChardan CapitalAnalyst Y. LivshitsBuy $21.00High
VINC
Vincerx
1/6/2021Initiated byChardan CapitalAnalyst Geulah LivshitsBuy $33.00N/A
PRVB
Provention Bio
1/4/2021Target Raised byChardan CapitalPositive -> Buy$35.00 -> $40.00N/A
CWBR
CohBar
12/23/2020Reiterated byChardan CapitalAnalyst M. MorabitoBuyN/A
CWBR
CohBar
12/17/2020Initiated byChardan CapitalBuy $3.00High
VBLT
Vascular Biogenics
12/10/2020Reiterated byChardan CapitalAnalyst Y. LivshitsBuyLow
CRSP
CRISPR Therapeutics
12/10/2020Target Raised byChardan CapitalAnalyst Geulah LivshitsBuy$110.00 -> $166.00High
RCKT
Rocket Pharmaceuticals
12/8/2020Target Raised byChardan CapitalAnalyst Geulah LivshitsPositive -> Buy$35.00 -> $46.00High
MESO
Mesoblast
12/4/2020Downgraded byChardan CapitalAnalyst K. NakaeNeutral -> Sell$5.50 -> $7.50High
AXLA
Axcella Health
11/26/2020Reiterated byChardan CapitalAnalyst M. MorabitoBuy $16.00Low
DRRX
DURECT
11/26/2020Reiterated byChardan CapitalAnalyst M. MorabitoBuy $7.00Low
ABUS
Arbutus Biopharma
11/16/2020Reiterated byChardan CapitalAnalyst Keay NakaeBuy $5.00Low
MRNA
Moderna
11/16/2020Target Raised byChardan CapitalAnalyst Geulah LivshitsPositive -> Buy$93.00 -> $107.00High
IMVT
Immunovant
11/12/2020Target Raised byChardan CapitalAnalyst Gbola Amusa$45.00 -> $60.00High
PASG
Passage Bio
11/12/2020Reiterated byChardan CapitalAnalyst Gbola AmusaBuy $32.50Medium
FBRX
Forte Biosciences
11/11/2020Target Raised byChardan CapitalAnalyst G. Amusa$110.00 -> $115.00Low
ICPT
Intercept Pharmaceuticals
11/10/2020Target Lowered byChardan CapitalAnalyst Michael MorabitoBuy$105.00 -> $58.00High
MDGL
Madrigal Pharmaceuticals
11/6/2020Reiterated byChardan CapitalAnalyst M. MorabitoBuy $205.00Medium
PRVB
Provention Bio
11/3/2020Reiterated byChardan CapitalAnalyst Gbola AmusaBuy $35.00Medium
DRRX
DURECT
10/30/2020Initiated byChardan CapitalAnalyst M. MorabitoBuy $7.00Medium
AXLA
Axcella Health
10/27/2020Initiated byChardan CapitalAnalyst M. MorabitoBuy $16.00Medium
IMNM
Immunome
10/27/2020Initiated byChardan CapitalAnalyst Geulah LivshitsBuy $18.00High
CRSP
CRISPR Therapeutics
10/22/2020Target Raised byChardan CapitalAnalyst Geulah LivshitsPositive -> Buy$100.00 -> $110.00High
NGM
NGM Biopharmaceuticals
10/20/2020Reiterated byChardan CapitalAnalyst M. MorabitoBuy $39.00High
TSHA
Taysha Gene Therapies
10/19/2020Initiated byChardan CapitalAnalyst G. AmusaBuy $45.00High
RCKT
Rocket Pharmaceuticals
10/16/2020Target Raised byChardan CapitalAnalyst Geulah LivshitsBuy$33.00 -> $35.00High
REPL
Replimune Group
10/14/2020Target Raised byChardan CapitalAnalyst Geulah LivshitsBuy$30.00 -> $48.00High
ALNY
Alnylam Pharmaceuticals
10/12/2020Reiterated byChardan CapitalBuyLow
MRNA
Moderna
10/8/2020Target Lowered byChardan CapitalAnalyst Geulah LivshitsBuy$95.00 -> $93.00Low
IOVA
Iovance Biotherapeutics
10/6/2020Reiterated byChardan CapitalAnalyst Geulah LivshitsBuy$53.00 -> $50.00High
SLDB
Solid Biosciences
10/1/2020Target Raised byChardan CapitalAnalyst Gbola AmusaBuy$5.00 -> $12.50High
FBRX
Forte Biosciences
9/24/2020Target Raised byChardan CapitalAnalyst G. AmusaBuy$60.00 -> $110.00High
IVA
Inventiva
9/21/2020Reiterated byChardan CapitalAnalyst M. MorabitoNeutralLow
MCRB
Seres Therapeutics
9/18/2020Downgraded byChardan CapitalAnalyst Gbola AmusaBuy -> Neutral$32.50 -> $27.50Medium
SYBX
Synlogic
9/18/2020Reiterated byChardan CapitalBuy $5.00Medium
XCUR
Exicure
9/17/2020Target Raised byChardan CapitalAnalyst Keay NakaeBuy$5.00 -> $7.00High
ETNB
89bio
9/15/2020Target Raised byChardan CapitalAnalyst Michael MorabitoBuy$59.00 -> $95.00High
FBRX
Forte Biosciences
9/10/2020Target Raised byChardan CapitalAnalyst G. AmusaBuy$45.00 -> $60.00High
SONN
Sonnet BioTherapeutics
9/3/2020Target Raised byChardan CapitalAnalyst Keay NakaePositive -> Buy$7.00 -> $8.00Medium
VKTX
Viking Therapeutics
8/31/2020Target Raised byChardan CapitalAnalyst Michael MorabitoBuy$15.00 -> $20.00Medium
ABUS
Arbutus Biopharma
8/28/2020Reiterated byChardan CapitalAnalyst Keay NakaeBuy $5.00Low
FBRX
Forte Biosciences
8/28/2020Upgraded byChardan CapitalAnalyst G. AmusaNeutral -> Buy $45.00High
KRYS
Krystal Biotech
8/25/2020Reiterated byChardan CapitalAnalyst Gbola AmusaBuy $115.00Low

MarketBeat Community Rating for Chardan Capital

Community Ranking:  2.8 out of 5 (
2.8 of 5 stars)
Outperform Votes:  17,754 (Vote Outperform)
Underperform Votes:  14,141 (Vote Underperform)
Total Votes:  31,895
MarketBeat's community ratings are surveys of what our community members think about Chardan Capital and other research firms. Vote "Outperform" if you believe Chardan Capital's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Chardan Capital's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.